16412606

Source:http://linkedlifedata.com/resource/pubmed/id/16412606

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005684, umls-concept:C0030705, umls-concept:C0080055, umls-concept:C0332391, umls-concept:C1171362, umls-concept:C1333543, umls-concept:C1421834
pubmed:issue	2
pubmed:dateCreated	2006-2-21
pubmed:abstractText	This study is designed to evaluate the expression and prognostic value of FGFR3 protein expression in patients with pTa/pT1 tumours and to determine the significance of the combinations of FGFR3 and p53 protein expressions in bladder pathogenesis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8504356
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/FGFR3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Fibroblast Growth..., http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0748-7983
pubmed:author	pubmed-author:BeckAA, pubmed-author:CheneyR TRT, pubmed-author:FischerGG, pubmed-author:HerrmannF RFR, pubmed-author:Mhawech-FaucegliaPP
pubmed:issnType	Print
pubmed:volume	32
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	231-7
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:16412606-Adult, pubmed-meshheading:16412606-Aged, pubmed-meshheading:16412606-Aged, 80 and over, pubmed-meshheading:16412606-Analysis of Variance, pubmed-meshheading:16412606-Antibodies, Monoclonal, pubmed-meshheading:16412606-Carcinoma, Transitional Cell, pubmed-meshheading:16412606-Chemotherapy, Adjuvant, pubmed-meshheading:16412606-Disease Progression, pubmed-meshheading:16412606-Female, pubmed-meshheading:16412606-Follow-Up Studies, pubmed-meshheading:16412606-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16412606-Humans, pubmed-meshheading:16412606-Male, pubmed-meshheading:16412606-Middle Aged, pubmed-meshheading:16412606-Neoplasm Recurrence, Local, pubmed-meshheading:16412606-Neoplasm Staging, pubmed-meshheading:16412606-Phenotype, pubmed-meshheading:16412606-Prognosis, pubmed-meshheading:16412606-Receptor, Fibroblast Growth Factor, Type 3, pubmed-meshheading:16412606-Retrospective Studies, pubmed-meshheading:16412606-Tumor Suppressor Protein p53, pubmed-meshheading:16412606-Urinary Bladder Neoplasms, pubmed-meshheading:16412606-Urologic Surgical Procedures
pubmed:year	2006
pubmed:articleTitle	FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer.
pubmed:affiliation	Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Elm and Carlton Street, Buffalo, NY 14263, USA. pmhawech1@yahoo.com
pubmed:publicationType	Journal Article